相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Presynaptic calcium channels: specialized control of synaptic neurotransmitter release
Annette C. Dolphin et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and Production
Kathrin Laura Kohnen-Johannsen et al.
MOLECULES (2019)
Novel long-acting antagonists of muscarinic ACh receptors
Alena Randakova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease
Evanthia Nanou et al.
NEURON (2018)
Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins
Andrea Pathe-Neuschaefer-Rube et al.
TOXINS (2018)
Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
Hongtao Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Calcium channel modulation as a target in chronic pain control
Ryan Patel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The Role of Calcium Channels in Epilepsy
Sanjeev Rajakulendran et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
DOPAMINE MIDBRAIN NEURONS IN HEALTH AND PARKINSON'S DISEASE: EMERGING ROLES OF VOLTAGE-GATED CALCIUM CHANNELS AND ATP-SENSITIVE POTASSIUM CHANNELS
E. Dragicevic et al.
NEUROSCIENCE (2015)
Botulinum Neurotoxin Dose-Dependently Inhibits Release of Neurosecretory Vesicle-Targeted Luciferase from Neuronal Cells
Andrea Pathe-Neuschaefer-Rube et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2015)
Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction
Elisa Duregotti et al.
TOXINS (2015)
Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels
David J. Adams et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Cholinergic Dysfunction in Parkinson's Disease
Martijn L. T. M. Mueller et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Pharmacological Inhibition of Voltage-gated Ca2+ Channels for Chronic Pain Relief
Bentham Science Publisher Bentham Science Publisher
Current Neuropharmacology (2013)
Expression and Pharmacology of Endogenous Cav Channels in SH-SY5Y Human Neuroblastoma Cells
Silmara R. Sousa et al.
PLOS ONE (2013)
Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain
S. Vink et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine
Thimmappa S. Anekonda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
E. Ilijic et al.
NEUROBIOLOGY OF DISEASE (2011)
Scopolamine (hyoscine) for preventing and treating motion sickness
Anneliese Spinks et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Calcium overload in nerve terminals of cultured neurons intoxicated by alpha-latrotoxin and snake PLA2 neurotoxins
Erik Tedesco et al.
TOXICON (2009)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Cholinergic dysfunction in temporal lobe epilepsy
Alon Friedman et al.
EPILEPSIA (2007)
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels
WA Catterall et al.
PHARMACOLOGICAL REVIEWS (2005)
Conotoxins as selective inhibitors of neuronal ion channels, receptors and transporters
RJ Lewis
IUBMB LIFE (2004)
Neuronal Cav1.3α1 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines
WF Xu et al.
JOURNAL OF NEUROSCIENCE (2001)
alpha-Latrotoxin and its receptors: Neurexins and Cirl/latrophilins
TC Sudhof
ANNUAL REVIEW OF NEUROSCIENCE (2001)
分享论文
